Retatrutide (30mg)

30mg Retatrutide peptide supplied in Australia — extended-protocol vial covering approximately 15 weeks at 2mg/week. Triple GLP-1/GIP/Glucagon receptor agonist with Phase 2 data showing up to 24% mean body weight reduction. High-purity lyophilized powder with verified CoA and fast domestic shipping.